Article Details
Retrieved on: 2021-02-04 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution.
Article found on: www.argus-press.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here